Prospective study identifies in-hospital mortality predictors in STEMI patients with no-reflow phenomenon, suggesting implications for treatment outcomes.
The mortality rate in subjects with ST-segment elevation acute myocardial infarction (STEMI) is increased because of short- and long-term complications. Purpose Our study aims to reveal the death risk and in-hospital mortality predictors in STEMI patients who develop no-reflow phenomenon after primary percutaneous coronary intervention (PCI). Material and method Between 01.01.2016–31.03.2018, we performed a prospective study including 656 patients with STEMI. We included only patients who underwent myocardial revascularization through the primary PCI method and developed no-reflow phenomenon. Results Our study included 96 patients with STEMI and no-reflow phenomenon after PCI, of whom 14 died. Mortality rate was significantly higher in subjects with anterior STEMI compared with inferior STEMI (42.9% vs. 14.3%). The mortality registered after PCI was significantly higher in the coronary no-reflow phenomenon group compared with the myocardial no-reflow group ( p = 0.039). Post-PCI mortality was significantly higher in patients with complications than in those without complications (33.33% vs. 1.75%, p <0.001). Conclusions The coronary no-reflow phenomenon has the highest risk of mortality, accounting for more than half of the myocardial infarction cases compared with the myocardial no-reflow phenomenon. Most of the deaths were reported in subjects with STEMI and the no-reflow phenomenon, who developed cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Pantea-Roșan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: